Organovo (NASDAQ: ONVO) reported Q4 EPS of ($0.10), versus ($0.09) reported last year. Revenue for the quarter came in at $812 thousand, versus $548 thousand reported last year.

GUIDANCE:

Organovo sees FY2018 revenue of $6-8.5 million.

• Negative Adjusted EBITDA of between $29.0 million and $31.0 million for fiscal-year 2018. Fiscal 2017 negative Adjusted EBITDA was $29.8 million.

For earnings history and earnings-related data on Organovo (ONVO) click here.